Abstracts Submission Guidelines

  • All abstracts must be submitted exclusively through the online platform before February 22nd  at 09.00 (Local Swiss time)
  • - Abstracts received after this deadline will not be considered.
    - Abstracts submitted by email or post mail will not be accepted
  • Abstracts must only be submitted in English.


  • The material submitted should be unpublished and not have been presented in any other meeting.
  • Please, state in the system who will be the corresponding author (contact person). This person will receive all the notifications.
  • Please, state in the system who will be the presenting author.
    IMPORTANT: Note that every author may submit and appear as co-author in several abstracts but ONLY WILL BE ABLE TO PRESENT ONE ABSTRACT. That means that every registered person can present only ONE Oral or Poster presentation.
  • Presenting authors whose abstract have been accepted must  register for the Congress. Failure to do so will result in exclusion from the Congress Programme
  • Authors are requested to indicate their preference for ORAL or POSTER presentation. However, the final status will be decided by the Scientific Committee.
Authors are urged to carefully consider the list of topics, before indicating the appropriate topic for their abstract. The list of topics is as follows:

  • New Technologies in PGT
  • Approaches for embryo viability assessment
  • Clinical outcomes in PGT-A
  • PGT for monogenic diseases & translocations (PGT-M & PGT-SR)
  • PGT Safety
  • Non- invasive PND and PGT
  • Prospective carrier screening and its impact on PGT application
  • Challenges in PGT for epigenetic conditions and gene editing
Abstract title:
Do not use capital letters and do not indent. The title should reflect the contents and should not exceed 150 characters (15 words).

Authors are requested to mention a minimum of two and a maximum of five keywords.

Abstract :
Must be a maximum of 500 words. The different section titles of the abstract - introduction, material and methods, results, conclusions - are to be typed in bold.
  • Introduction: should be informative and short, stating why the study was conducted.
  • Material & methods: should indicate the locale, number and type of human subjects, non-human species or material being studied, the principal procedures, assays, tests or treatments performed
  • Results: should confirm or refute the hypothesis, supported by statistics if appropriate.
  • Conclusions: should state the major new findings of the study and specify what these findings add to what is already known.
Please make sure you check your abstract carefully before sending it. No modifications will be made after submission’s deadline

In text references
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). It is not recommended that references are cited in the abstract but if for some reason they must be, they must also be given in full in the reference list. Unpublished results are not recommended in the reference list but may be mentioned in the text. Exceptionally, if unpublished references are included in the reference list, they should follow the standard reference style of the journal and should include a substitution of the publication date with "Unpublished results". Personal communications are not allowed in the reference list, but may be mentioned in the text where the name and brief address of the person must also be supplied. Citation of a reference as "in press" implies that the item has been accepted for publication.

Web references
As a minimum, the full URL should be given. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included in the reference list.

Reference list
Please provide name and initial(s) for all authors, followed by year of publication. References should be arranged first alphabetically and then further sorted chronologically, if necessary.

Citation Style
All citations in the text should refer to:

  • Single author: the author's name (without initials, unless there is ambiguity) and the year of publication;
  • Two authors: both authors' names and the year of publication;
  • More than three authors: first author's name followed by "et al." and the year of publication.
Citations may be made directly (or parenthetically). Groups of references should be listed first alphabetically, then chronologically.


Author names and affiliations: Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Institution, department and location are requested from all authors.

Authors' affiliation should include the addresses (where the actual work was done).

Corresponding author: Clearly indicate who will handle correspondence at all stages of refereeing and publication (and post-publication).

Contact Information: Ensure the information provided is correct and make sure contact details (phone number and email) are right for corresponding author and presenting author.


All abstracts will be reviewed anonymously.

Abstracts submitted for oral or poster presentation will be evaluated by the Scientific Committee. Once an abstract is accepted, the Committee will decide whether it is to be presented as an oral or as a poster

Oral Presentations
Each presentation, to be given by the author, should last no more than 10 minutes and will be  followed by a 5-minute discussion period. Authors will be informed of the day and time of each oral presentation in the letter of acceptance of their abstract.

Poster Presentations
Authors of those abstracts accepted for poster presentation will be notified of the day and time of their poster session. During the poster session, one of the authors must be available at the specified times to answer questions from attendees.

Information about the size and format of the posters will be given to authors in their letter of acceptance.

ImagotipoBlancoCalle Castelló, 128-7ª Panta | 28006 Madrid (SPAIN)
Tel. +34 913 836 000 | Fax. +34 913 023 926
This email address is being protected from spambots. You need JavaScript enabled to view it.
Website created by:
Grupo Pacífico